Therapy Cells, Inc - TCEL

0.0008
USD +0.0005 (1.6667%)
Volume: 18,064,405
Trade

Therapy Cells, Inc. develops and commercializes a technology for tendon repair for the human market. Its technology is used for tissue transplantation to aid in the repair and regeneration of damaged, diseased, torn, or ruptured musculoskeletal cells and organs in the human, as well as to grow pancreatic cells, for treatment of diabetes, cardiac cells for the treatment of heart disease, and other cell types from various other tissues. The company was formerly known as Diamond Information Institute, Inc. and changed its name to Therapy Cells, Inc. in May 2011. Therapy Cells, Inc. was founded in 1988 and is based in Las Vegas, Nevada.

Trade Therapy Cells, Inc at these brokers
1 2 3 4 5 6 7 8 9 10
3.75
  • Platforms: Andriod App, iOS App, Mobile App, WebTrader
  • License: Not Applicable
Your capital is at risk
1 2 3 4 5 6 7 8 9 10
3.75
  • Platforms: Andriod App, Apple App, iOS App, MetaTrader 4, MetaTrader 5, Mobile App, Proprietary, WebTrader
  • License: CySEC, FCA UK
Your capital is at risk
1 2 3 4 5 6 7 8 9 10
4.5
  • Platforms: Andriod App, Apple App, iOS App, Mobile App, WebTrader
  • License: ASIC, CySEC, FCA UK
Your capital is at risk